ライフサイエンスコーパス: endothelial progenitor cell

1 ycerol sebacate)) with a single cell source (endothelial progenitor cells).

2 linase in microparticle-induced apoptosis of endothelial progenitor cells.

3 nhance the benefit of stem cell therapy with endothelial progenitor cells.

4 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

5 lial marker CD31, suggesting the presence of endothelial progenitor cells.

6 in these hematopoietic tissues gives rise to endothelial progenitor cells.

7 epletion restores the functional capacity of endothelial progenitor cells.

8 It has also been used to identify endothelial progenitor cells.

9 associated with mobilization of circulating endothelial progenitor cells.

10 t abnormalities in phenotype and function of endothelial progenitor cells.

11 f promoting endothelial regeneration through endothelial progenitor cells.

12 ng a mixture of cardiac progenitor cells and endothelial progenitor cells.

13 th tumor endothelial and bone marrow-derived endothelial progenitor cells.

14 cripts in ischemic tissue and in circulating endothelial progenitor cells.

15 air of injured microvasculature by providing endothelial progenitor cells.

16 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

17 of edema, and depletion of regulatory T and endothelial progenitor cells.

18 ability to differentiate into erythroid and endothelial progenitor cells.

19 Endometriotic lesions increased circulating endothelial progenitor cells 13 days after engraftment,

20 eated with intramuscular bone marrow-derived endothelial progenitor cells [2.0 x 10 cells]), group 4

21 e of a role for bone marrow-derived putative endothelial progenitor cells after iatrogenic vascular i

22 to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribron

23 ntly increased numbers of VEGFR2(+)/AC133(+) endothelial progenitor cells and CD34(+)/VEGFR1(+) hemat

24 Combined treatment with bone marrow-derived endothelial progenitor cells and extracorporeal shock wa

25 hips, which expands their endogenous pool of endothelial progenitor cells and generates vascular netw

26 Next, resident endothelial progenitor cells and hematopoietic stem cell

27 Exogenous uric acid rapidly mobilizes endothelial progenitor cells and hematopoietic stem cell

28 l plaque volume but does stabilize levels of endothelial progenitor cells and improve microvascular f

29 r analog [ESA]) induces continuous homing of endothelial progenitor cells and improves left ventricul

30 nrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnata

31 actor-1 (SDF-1) is a chemokine that attracts endothelial progenitor cells and promotes angiogenesis.

32 IL-1beta and IL-18, and coadministration of endothelial progenitor cells and stromal cell-derived fa

33 stigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic

34 icity of cardiac fibroblasts and circulating endothelial progenitor cells, and consider what role the

35 ty over the precise identity and function of endothelial progenitor cells, and harnessing their thera

36 es consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells

37 Signaling between endothelial cells, endothelial progenitor cells, and stromal cells is cruci

38 ently, it remains controversial how vascular endothelial progenitor cells (angioblasts) establish the

39 s process is recapitulated in the adult when endothelial progenitor cells are generated in the bone m

40 d cardiovascular progenitor cells, including endothelial progenitor cells, are capable of replacing d

41 The CACs, also termed endothelial progenitor cells, are critical for vascular

42 or cells, rhG-CSF can mobilize dendritic and endothelial progenitor cells as well.

43 Endothelial progenitor cells, as well as HSC/HPCs, were

44 We discovered that bone marrow-derived endothelial progenitor cells (BM-EPC), having the phenot

45 ating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs).

46 very high degree of deletion in hemopoietic/endothelial progenitor cells but without deletion among

47 rentiated them to both endothelial cells and endothelial progenitor cells by using the embryoid body

48 as well as numbers of inflammatory cells and endothelial progenitor cells (c-kit+/CD31+ cells) in bot

49 Endothelial progenitor cells can restore vessel wall fun

50 forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis i

51 n in primary tumors, including expression of endothelial progenitor cell (CD133 and CD34) and endothe

52 owever, the source of these culture-expanded endothelial progenitor cells (CE-EPCs) remains controver

53 n of ADAM17, modulates postnatal circulating endothelial progenitor cell (CEPC) numbers via effects o

54 Circulating endothelial progenitor cells (cEPCs) are known to contri

55 tem that sustains the release of a bioactive endothelial progenitor cell chemokine during a 4-week pe

56 eeks in vitro, remained active, and enhanced endothelial progenitor cell chemotaxis.

57 t peripheral blood (PB) cytokines predict BM endothelial progenitor cell colony outgrowth and cardiac

58 y safety and primary efficacy end points and endothelial progenitor cell colony-forming unit mobiliza

59 There was robust endothelial progenitor cell colony-forming unit mobiliza

60 Endothelial progenitor cells contribute to vascular repa

61 Endothelial/endothelial progenitor cells derived from iPS cells expr

62 ogenitor cell mobilization from bone marrow, endothelial progenitor cell differentiation, and ultimat

63 ndothelial nitric oxide synthase-transfected endothelial progenitor cells, divided into 3 doses on co

64 etwork mediating developmental plasticity of endothelial progenitor cells during embryonic developmen

65 us mechanism of Hh signaling in angioblasts (endothelial progenitor cells) during arterial-venous spe

66 more, conditioned medium (CM) from embryonic endothelial progenitor cells (eEPCs) rescued the follicu

67 ation system can detect endothelial cell and endothelial progenitor cell (EPC) activation in vitro an

68 of endothelial cell and bone marrow-derived endothelial progenitor cell (EPC) activity.

69 w PA diabetic (d-PA) concentrations affected endothelial progenitor cell (EPC) and bone marrow-derive

70 ion compromises the reparative properties of endothelial progenitor cell (EPC) and their exosomes on

71 Endothelial progenitor cell (EPC) counts are proposed su

72 regard to endothelial vasodilatory function, endothelial progenitor cell (EPC) function, in vivo neoa

73 y increased vascular senescence and impaired endothelial progenitor cell (EPC) function.

74 Reendothelialization involves endothelial progenitor cell (EPC) homing, proliferation,

75 number and impaired physiology of endogenous endothelial progenitor cell (EPC) population that limits

76 ine human microvascular EC (HMVEC) and human endothelial progenitor cell (EPC) recruitment into engra

77 wound closure rates, neovascularization, and endothelial progenitor cell (EPC) recruitment.

78 gical effects after bone marrow (BM)-derived endothelial progenitor cell (EPC) transplantation into i

79 cumented the role of SIRT1 in reduced EC and endothelial progenitor cell (EPC) viability.

80 h-mobility-group-box-1 (HMGB1) that promotes endothelial progenitor cell (EPC)-mediated neurovascular

81 impaired Lin(-)cKit(+)Sca1(+) (LKS) cell and endothelial progenitor cell (EPC; CD34(+)Flk1(+)) mobili

82 ndothelial cells, thus tethering circulating endothelial progenitor cells (EPC) and facilitating homi

83 Endothelial progenitor cells (EPC) are able to migrate t

84 Bone marrow-derived endothelial progenitor cells (EPC) contribute to the ang

85 s (GSKi) can improve therapeutic efficacy of endothelial progenitor cells (EPC) from patients with DM

86 cal animal models, early clinical studies of endothelial progenitor cells (EPC) have begun.

87 derived from the intended recipient--either endothelial progenitor cells (EPC) or endothelial cell (

88 (SDF-1alpha, a homing signal for recruiting endothelial progenitor cells (EPC) to areas of neovascul

89 Homing of endothelial progenitor cells (EPC) to the ischemic tissu

90 Endothelial progenitor cells (EPC) were successfully cul

91 d cancer progression for bone marrow-derived endothelial progenitor cells (EPC).

92 ed to the recruitment of bone marrow-derived endothelial progenitor cells (EPC).

93 angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC).

94 otransplantation of peripheral blood-derived endothelial progenitor cells (EPCs) and bone marrow-deri

95 Herein, mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs) and c-Kit(+) cardiac

96 to impairments in vascular repair induced by endothelial progenitor cells (EPCs) and circulating angi

97 study was to determine whether the number of endothelial progenitor cells (EPCs) and circulating angi

98 s were supported by in vitro observations on endothelial progenitor cells (EPCs) and endothelial cell

99 tified endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs) and evaluated, in 24

100 l (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) and favorably affect

101 and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angioge

102 ll apoptosis and vascular repair mediated by endothelial progenitor cells (EPCs) and myeloid circulat

103 Endothelial progenitor cells (EPCs) and myelomonocytic c

104 The number of circulating endothelial progenitor cells (EPCs) and plasma levels of

105 ed the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from n

106 Endothelial progenitor cells (EPCs) are a heterogeneous

107 l cells, and form new vessels, blood-derived endothelial progenitor cells (EPCs) are attractive sourc

108 rculating progenitor cells (CPCs), including endothelial progenitor cells (EPCs) are biologically rel

109 Endothelial progenitor cells (EPCs) are decreased in num

110 Endothelial progenitor cells (EPCs) are essential in vas

111 Marrow-derived endothelial progenitor cells (EPCs) are important in the

112 Mobilization and functions of endothelial progenitor cells (EPCs) are increased in pat

113 Endothelial progenitor cells (EPCs) are known to promote

114 Endothelial progenitor cells (EPCs) are present in the s

115 Circulating endothelial progenitor cells (EPCs) are thought to contr

116 Diverse subsets of endothelial progenitor cells (EPCs) are used for the tre

117 stasis, we identify bone marrow (BM)-derived endothelial progenitor cells (EPCs) as critical regulato

118 ct MVs shed from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbe

119 ic platform capable of capturing circulating endothelial progenitor cells (EPCs) by understanding sur

120 by extracellular matrix scaffold seeded with endothelial progenitor cells (EPCs) can overcome these l

121 Endothelial progenitor cells (EPCs) can participate with

122 Valvular endothelial cells and circulating endothelial progenitor cells (EPCs) can undergo apparent

123 ata have shown that bone marrow (BM)-derived endothelial progenitor cells (EPCs) contribute to endoth

124 Endothelial progenitor cells (EPCs) contribute to postna

125 Endothelial progenitor cells (EPCs) contribute to vascul

126 etic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly

127 D133(+) and CD34(+) CPCs as well as cultured endothelial progenitor cells (EPCs) derived from blood m

128 In the present study we hypothesized that endothelial progenitor cells (EPCs) enhance production o

129 Endothelial progenitor cells (EPCs) enter the systemic c

130 therosclerosis have increases in circulating endothelial progenitor cells (EPCs) expressing an osteog

131 siderable interest in exploiting circulating endothelial progenitor cells (EPCs) for therapeutic orga

132 We have previously shown that human endothelial progenitor cells (EPCs) form functioning ves

133 infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow

134 xia enhances the mobilization of circulating endothelial progenitor cells (EPCs) from the bone marrow

135 n in the control of regenerative function of endothelial progenitor cells (EPCs) has not been studied

136 Reduced levels of endothelial progenitor cells (EPCs) have been associated

137 Endothelial progenitor cells (EPCs) have been associated

138 Although different substances that mobilize endothelial progenitor cells (EPCs) have been proposed,

139 Endothelial progenitor cells (EPCs) have been shown to a

140 Bone marrow-derived endothelial progenitor cells (EPCs) have the ability to

141 We hypothesize that blood-derived endothelial progenitor cells (EPCs) have the required pr

142 Little is known about the role of endothelial progenitor cells (EPCs) in atherosclerosis.

143 We aimed to determine the role of endothelial progenitor cells (EPCs) in cholinergic angio

144 Endothelial progenitor cells (EPCs) in ESA gradient, ass

145 The discovery of endothelial progenitor cells (EPCs) in human peripheral

146 ggest a critical role of bone marrow-derived endothelial progenitor cells (EPCs) in neovascularizatio

147 Diabetic individuals have fewer endothelial progenitor cells (EPCs) in their circulation

148 Migration of endothelial progenitor cells (EPCs) into areas of vascul

149 The incorporation of endothelial progenitor cells (EPCs) into microvessels co

150 The incorporation of endothelial progenitor cells (EPCs) into newly developin

151 e limited vessel-forming capacity of infused endothelial progenitor cells (EPCs) into patients with c

152 Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging conce

153 Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging thera

154 Vascular repair by marrow-derived endothelial progenitor cells (EPCs) is impaired during d

155 d on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known.

156 Endothelial progenitor cells (EPCs) may be relevant cont

157 Endothelial progenitor cells (EPCs) normally augment ang

158 (SHS) exposure on the number and function of endothelial progenitor cells (EPCs) over 24 h.

159 Because endothelial progenitor cells (EPCs) participate in this

160 In adults, circulating endothelial progenitor cells (EPCs) participate in vascu

161 Endothelial progenitor cells (EPCs) play a critical role

162 Endothelial progenitor cells (EPCs) play an important ro

163 Endothelial progenitor cells (EPCs) promote neovasculari

164 and circulating progenitor cells (CPCs) and endothelial progenitor cells (EPCs) PTH, and genetic par

165 Late outgrowth endothelial progenitor cells (EPCs) represent a promisin

166 only isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion t

167 n (TBI) and then infused with C57Bl6-derived endothelial progenitor cells (EPCs) to augment endogenou

168 that estradiol can modulate the kinetics of endothelial progenitor cells (EPCs) via endothelial nitr

169 Endothelial progenitor cells (EPCs) was assayed by flow

170 Endothelial progenitor cells (EPCs) were cultured on the

171 carotid arteries and circulating numbers of endothelial progenitor cells (EPCs) were examined after

172 Circulating endothelial progenitor cells (EPCs) were quantified at b

173 e number of bone marrow and peripheral blood endothelial progenitor cells (EPCs), a marker of vascula

174 mas are composed of endothelial cells (ECs), endothelial progenitor cells (EPCs), as well as perivasc

175 ase, by causing a reduction in the number of endothelial progenitor cells (EPCs), bone marrow-derived

176 Flow cytometry was applied to quantify endothelial progenitor cells (EPCs), circulating endothe

177 Endothelial progenitor cells (EPCs), critical for mediat

178 Endothelial progenitor cells (EPCs), defined as CD34(+)V

179 We hypothesized that adriamycin affects endothelial progenitor cells (EPCs), leading to impaired

180 at PAH patients are deficient in circulating endothelial progenitor cells (EPCs), potentially contrib

181 nclude endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs), respectively.

182 Since the discovery of endothelial progenitor cells (EPCs), there have been con

183 the mobilization of bone marrow (BM)-derived endothelial progenitor cells (EPCs), thereby enhancing n

184 is associated with a deficit of circulating endothelial progenitor cells (EPCs), which has been attr

185 have profound effects on the endothelium and endothelial progenitor cells (EPCs), which originate fro

186 etic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain

187 eovascularization is controversial, but BMD--endothelial progenitor cells (EPCs)--are strongly implic

188 cells (CECs), angiogenic growth factors, and endothelial progenitor cells (EPCs).

189 e-induced recruitment of bone marrow-derived endothelial progenitor cells (EPCs).

190 Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs).

191 novo recruitment of bone marrow (BM)-derived endothelial progenitor cells (EPCs).

192 ther mobilization or survival of circulating endothelial progenitor cells (EPCs).

193 repair by regenerative endothelial cells and endothelial progenitor cells (EPCs).

194 ), and group 5 (combined bone marrow-derived endothelial progenitor cell-extracorporeal shock wave) a

195 During embryogenesis, lymphatic endothelial progenitor cells first arise from a subset o

196 we demonstrate the isolation of CD34+/Flk1+ endothelial progenitor cells from blood enabled by the d

197 ing mature endothelial cells and circulating endothelial progenitor cells from septic shock and nonse

198 exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be ident

199 ent vasorelaxation of thoracic aortas and in endothelial progenitor cell function, as assessed by the

200 tric oxide (NO) is a key regulator of EC and endothelial progenitor cell function, but the pathophysi

201 e haemoglobin and modulates inflammation and endothelial progenitor cell function.

202 Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients

203 ically engineered mesenchymal stem cells and endothelial progenitor cells has been explored as a rege

204 In this new field, characterization of endothelial progenitor cells has presented new opportuni

205 bone marrow-derived cell populations, called endothelial progenitor cells, have been reported to poss

206 ish the effects of human bone marrow-derived endothelial progenitor cells (hBMEPCs) systemically tran

207 layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPCs) from a separate,

208 mal cell sheets (hMSC) as the wall and human endothelial progenitor cell (hEPC) coating as the lumen.

209 Human endothelial progenitor cells (hEPCs) participate in neov

210 release of SDF-1, a chemokine that promotes endothelial progenitor cell homing and angiogenesis, fro

211 the differentiation capacity of bone marrow endothelial progenitor cells, improved endothelium-depen

212 Since the identification of the endothelial progenitor cell in 1997 by Asahara and Isner

213 e assessed at multiple time points using rat endothelial progenitor cells in a transwell migration as

214 While evidence of the importance of endothelial progenitor cells in adult vasculogenesis inc

215 mor progression have 2-fold more circulating endothelial progenitor cells in peripheral blood than co

216 tometry was performed to measure circulating endothelial progenitor cells in peripheral blood.

217 The miR array data from endothelial progenitor cells in response to inflammatory

218 is expressed in tumor neovasculature and on endothelial progenitor cells in the bone marrow, was lab

219 , exhibited an increased number of lymphatic endothelial progenitor cells in the cardinal veins, toge

220 ining the role of murine bone marrow-derived endothelial progenitor cells in the process of tumor neo

221 This correlated with a 30% increase in endothelial progenitor cells in the retina at postnatal

222 By contrasting the role of endothelial progenitor cells in tissue regeneration with

223 lary density, as well as bone marrow-derived endothelial progenitor cells incorporation into the func

224 In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the pot

225 ance by CYP26B1 in the vicinity of lymphatic endothelial progenitor cells is important for determinin

226 Late outgrowth endothelial progenitor cells isolated from HPAH patients

227 g promotes differentiation and maturation of endothelial progenitor cells, its role in the differenti

228 sFlt1 with concomitant decreased circulating endothelial progenitor cell levels along with inappropri

229 Endothelial progenitor cell levels were highest in patie

230 Baseline flow-mediated dilation and endothelial progenitor cell levels were lower in patient

231 Circulating endothelial progenitor cell levels were quantified to as

232 ncy is associated with decreased circulating endothelial progenitor cells-like CD31(+)/c-Kit(+) cells

233 However, in contrast to endothelial progenitor cells, mature LSECs express littl

234 Further evidence suggests that stem cells or endothelial progenitor cells may be released from both b

235 vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proathero

236 ecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular

237 present study suggests that ischemia-induced endothelial progenitor cell-mediated neovascularization

238 corporeal shock wave and bone marrow-derived endothelial progenitor cells might exert enhanced protec

239 loading promoted osteoblast differentiation, endothelial progenitor cell migration, and tube formatio

240 scular endothelial growth factor expression, endothelial progenitor cell mobilization from bone marro

241 ypes, including hematopoietic stem cells and endothelial progenitor cells, more efficiently than the

242 roliferative capacity of ECs and circulating endothelial progenitor cell numbers after vascular injur

243 glitazone in improving endothelial function, endothelial progenitor cell numbers and functional capac

244 d Notch signaling increased Prox1+ lymphatic endothelial progenitor cell numbers in the veins, leadin

245 under oxidative stress, as well as decreased endothelial progenitor cell numbers were responsible for

246 and significantly increased Prox1+ lymphatic endothelial progenitor cell numbers.

247 mation of a vascular network from individual endothelial progenitor cells occurring during embryonic

248 ylation in cord blood-derived late outgrowth endothelial progenitor cells (OEPCs).

249 ECs expanded from blood-derived endothelial progenitor cells of VWD patients confirmed t

250 ve is superior to either bone marrow-derived endothelial progenitor cells or extracorporeal shock wav

251 eproduced in vitro by incubation of cultured endothelial progenitor cells or spleen-derived endotheli

252 such as peripheral hematopoietic stem cells, endothelial progenitor cells, or circulating tumor cells

253 Delivery of endothelial progenitor cells overexpressing endothelial

254 ematopoietic stem cells and depleted splenic endothelial progenitor cells, partially reproducing the

255 To clarify the origin of endothelial progenitor cells participating in endothelia

256 Participants underwent endothelial progenitor cell phenotyping with an early-ou

257 Putative endothelial progenitor cells play a role in organ regene

258 Multicolor flow cytometry quantified the endothelial progenitor cell population in the bone marro

259 further enriched by selection for a CD133(+) endothelial progenitor cell population.

260 ng living individuals, and its knock-down in endothelial progenitor cells precludes their capacity to

261 It has been demonstrated that endothelial progenitor cells present in the blood have a

262 lesions expressed markers characteristic of endothelial progenitor cells, produced angiogenic factor

263 Furthermore, Shh directly promoted endothelial progenitor cell proliferation, migration, ad

264 Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and M

265 The endothelial progenitor cell recently emerged as an impor

266 e enhancer identified here becomes active in endothelial progenitor cells shortly after their initial

267 pecimen was performed for endothelial cells, endothelial progenitor cells, smooth muscle cells, and i

268 Specifically, endothelial cell/endothelial progenitor cell survival, vascular endotheli

269 ain reaction and generated higher numbers of endothelial progenitor cells than CD31(-) cells did.

270 s study provides strong evidence in neonatal endothelial progenitor cells that GDM exposure in utero

271 abolites by gut endothelium requires MFSD2A; endothelial progenitor cells that overexpress MFSD2A red

272 Human circulating endothelial progenitor cells that overexpress MFSD2A wer

273 In mice with colitis, transplanted endothelial progenitor cells that overexpressed MFSD2A n

274 etic tissue can provide a source of vascular endothelial progenitor cells throughout life.

275 d (EECM), which differentiates hiPSC-derived endothelial progenitor cells to brain microvascular endo

276 The contribution of bone marrow (BM) endothelial progenitor cells to capillarization was iden

277 ls of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into matur

278 essed by the capacity of bone marrow-derived endothelial progenitor cells to differentiate into matur

279 en restored the resistance of both BMDCs and endothelial progenitor cells to oxidative stress, improv

280 ineered vessel can be seeded with autologous endothelial progenitor cells to provide a biological vas

281 the migration, recruitment, and retention of endothelial progenitor cells to sites of ischemic injury

282 igration of green fluorescent protein-tagged endothelial progenitor cells to tumor tissues.

283 study of the tolerability of culture-derived endothelial progenitor cells, transiently transfected wi

284 g tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not res

285 Enhanced apoptosis of endothelial progenitor cells under oxidative stress, as

286 including RhoA/Rho kinase, tyrosine kinase, endothelial progenitor cells, vasoactive intestinal pept

287 ized green fluorescent protein-Tie2-positive endothelial progenitor cells versus controls, with a cor

288 homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis,

289 The Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

290 with CLI (n=33) included in the Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

291 flammatory stimuli, the miR array profile of endothelial progenitor cells was analyzed using a polyme

292 he number of circulating bone marrow-derived endothelial progenitor cells was significantly reduced i

293 Endothelial progenitor cells were CD31+, vWF+, and alpha

294 Endothelial progenitor cells were not observed along the

295 The implanted endothelial progenitor cells were restricted to the lumi

296 Characterized ovine peripheral blood endothelial progenitor cells were seeded onto scaffolds

297 e that hematopoietic tissues are a source of endothelial progenitor cells, which contribute to newly

298 ed cellularity and altered the phenotypes of endothelial progenitor cells, which resulted in changes

299 uch a lentiviral vector can be used to endow endothelial progenitor cells with anti-tumor properties.

300 udy was to determine the role of circulating endothelial progenitor cells with osteoblastic phenotype